Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.51M Sell
76,883
-8,253
-10% -$666K 0.08% 107
2026
Q1
$6.08M Sell
85,136
-2,101,814
-96% -$157M 0.07% 105
2025
Q4
$172M Sell
2,186,950
-59,220
-3% -$4.69M 1.62% 23
2025
Q3
$184M Buy
2,246,170
+36,950
+2% +$2.91M 1.81% 20
2025
Q2
$179M Buy
2,209,220
+3,793
+0.2% +$293K 2.33% 16
2025
Q1
$177M Sell
2,205,427
-552,524
-20% -$46M 2.44% 18
2024
Q4
$224M Buy
2,757,951
+56,295
+2% +$4.68M 3.02% 11
2024
Q3
$221M Buy
2,701,656
+53,173
+2% +$3.97M 3.03% 15
2024
Q2
$187M Buy
2,648,483
+5,882
+0.2% +$420K 2.84% 16
2024
Q1
$196M Sell
2,642,601
-18,690
-0.7% -$1.3M 2.93% 12
2023
Q4
$177M Sell
2,661,291
-117,157
-4% -$7.33M 2.91% 15
2023
Q3
$175M Buy
2,778,448
+1,017,914
+58% +$63.4M 3.14% 14
2023
Q2
$99.8M Sell
1,760,534
-9,269
-0.5% -$514K 2.03% 18
2023
Q1
$103M Buy
+1,769,803
New +$119M 2.29% 18

Other funds holding MET

ABN AMRO Bank's MET Position: Q2 2026 in Review

ABN AMRO Bank reduced its MetLife (MET) stake by 9.7% in Q2 2026, selling an estimated $666K and leaving 76,883 shares worth $6.51M. The position accounts for 0.08% of the portfolio, ranked #107.

ABN AMRO Bank first reported a position in MET in Q1 2023 and has held it in 14 quarters since. The position peaked at $224M in Q4 2024. 1,442 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • ABN AMRO Bank held 76,883 shares of MetLife worth $6.51M as of Q2 2026.
  • ABN AMRO Bank sold 8,253 MetLife shares in Q2 2026, an estimated $666K.
  • MetLife made up 0.08% of ABN AMRO Bank's portfolio in Q2 2026, its #107 holding.
  • ABN AMRO Bank first reported a position in MetLife in Q1 2023 and has held it in 14 quarters since.
  • ABN AMRO Bank's MetLife position peaked at $224M in Q4 2024.
  • 1,442 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on ABN AMRO Bank's 13F filing for Q2 2026, filed 6 Aug 2026.